Stockreport

Tiziana to Advance TZLS-501 - Its Fully Human IL-6R Monoclonal Antibody

Tiziana Life Sciences Ltd - Common Shares  (TLSA) 
PDF BOSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), today announces it will advance its second asset, a [Read more]